Goločorbin Kon Svetlana, Iliković Ivana, Mikov Momir
Med Pregl. 2015 Jan-Feb;68(1-2):35-40. doi: 10.2298/mpns1502035g.
The application of drugs in accordance with the marketing authorization issued by the regulatory authority is considered on-label use, while off-label drug use frequently occurs in medical practice. It includes the application of drugs beyond approved indications; for unapproved age group, with different dosage regimens or different administration route. Medical specialists frequently prescribe an off-label drug in pediatrics, neonatology, geriatrics, psychiatry and oncology. Some countries have established registers of off-label drugs and guidelines for their prescribing and administration. The aim of the paper is to review practices in off-label drug use in order to satisfy the attitude of regulatory bodies and professional associations regarding the off-label use of drugs.
The sources of information used are articles published in scientific journals and information from the official websites of regulatory agencies.
The most common reasons why physicians decide to prescribe off-label drugs are primarily the absence of drugs for a particular indication or those for a particular age group. In their daily work, doctors prescribe drugs for an off-label use based on their own or other colleague's experience. There is no general agreement on off-label use of drugs at the national or international level, but more and more doctors' associations and regulatory bodies approve off-label drug use in compliance with certain scientific and legal requirements.
Off-label drug use has its place in practice and it has been widely accepted by the medical community and by itself it is not a violation of the standards of healthcare. Off-label use is common in our country and worldwide, and it is necessary to establish a registry for off-label drug use.
按照监管机构颁发的上市许可使用药物被视为标签内用药,而在医疗实践中,超说明书用药却屡见不鲜。它包括药物用于未经批准的适应证、用于未获批准的年龄组、采用不同的给药方案或不同的给药途径。医学专家在儿科、新生儿科、老年医学、精神病学和肿瘤学领域经常开具超说明书用药。一些国家已经建立了超说明书用药登记册以及关于其处方和用药的指南。本文旨在回顾超说明书用药的实践情况,以符合监管机构和专业协会对超说明书用药的态度。
所使用的信息来源是科学期刊上发表的文章以及监管机构官方网站的信息。
医生决定开具超说明书用药的最常见原因主要是特定适应证或特定年龄组的药物短缺。在日常工作中,医生根据自己或其他同事的经验开具超说明书用药。在国家或国际层面,对于超说明书用药尚无普遍共识,但越来越多的医生协会和监管机构在符合某些科学和法律要求的情况下批准超说明书用药。
超说明书用药在实践中有其存在的价值,并且已被医学界广泛接受,其本身并不违反医疗保健标准。超说明书用药在我国乃至全球都很常见,因此有必要建立一个超说明书用药登记册。